Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Exp Ther Med ; 21(3): 205, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33500698

RESUMO

The present study aimed to detect the levels of microRNA (miR)-33a-5p in the renal tissue, serum and urine of patients with primary IgA nephropathy (IgAN), thereby preliminarily exploring the association between the levels of miR-33a-5p and the condition of primary IgAN to provide evidence for the expression of miR-33a-5p in the serum and urine of IgAN patients as a clinical marker. Reverse-transcription quantitative PCR was performed to evaluate the level of miR-33a-5p in IgAN patients according to severity and pathological classification. The results suggested that the levels of miR-33a-5p in the serum, urine and kidney tissues of patients with IgAN were lower than those of the control tissues obtained from cancer patients (0.28±0.25 vs. 1.00±0.45, P<0.05; 0.34±0.28 vs. 1.00±0.53, P<0.05; 0.47±0.27 vs. 1.00±0.38, P<0.05, respectively). Receiver operating characteristic curve analysis suggested that the serum and urine levels of miR-33a-5p may be used as a marker to differentiate renal injury in IgAN patients from healthy individuals. At the same time, according to the estimated glomerular filtration rate (eGFR) and Lee classification of nephropathy, it was determined that with the progression of renal failure and the increase of the pathological grade of kidney tissue, the relative level of miR-33a-5p in kidney tissue also decreased (eGFR <50 ml/min vs. eGFR ≥50 ml/min/1.73 m2 group: 0.38±0.27 vs. 1.00±0.34, P<0.001; Lee grade ≤3 group vs. Lee grade >3: 1.00±0.48 vs. 0.38±0.45, P<0.05). This result suggested that the levels of miR-33a-5p in serum, urine and kidney tissues decreased with the severity of renal injury and the progression of renal failure in patients with IgAN. Hence, miR-33a-5p detected in the serum and urine may be used as a non-invasive biomarker to reflect the progression of renal injury and renal failure in patients with IgAN.

2.
Environ Sci Pollut Res Int ; 26(21): 21668-21681, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31129897

RESUMO

Farmland soil sprayed with organophosphorus pesticides (OPs) annually was investigated for the identification and characterization of OP-degrading microorganisms. Six bacterial strains were identified, including Brevundimonas faecalis MA-B12 and Alcaligenes faecalis subsp. parafaecalis MA-B13 for methamidophos degradation, Citrobacter freundii TF-B21 and Ochrobactrum intermedium TF-B23 for trichlorfon degradation, Ochrobactrum intermedium DV-B31 for dichlorvos degradation, and Bacillus cereus for dimethoate degradation. The optimal biodegradation conditions for OPs were obtained at pH 7.0 and incubation temperature ranging from 28 to 37 °C. In an 8-day batch test, biodegradation of the four OPs all followed first-order kinetics, with biodegradation rates ranging from 58.08 to 96.42%. Functional genes responsible for OPs degradation were obtained, including ophB, ampA, opdE, opd, opdA, and mpd. As these strains were indigenous strains isolated from farmland soils, they can be potentially used as bacterial consortium for the bioremediation of mixed OP-contaminated soils. A time-course genotoxicity assessment of the degradation products was done by a bacterial whole-cell bioreporter, revealing that biodegradation of trichlorfon, dichlorvos, and dimethoate resulted a decreased genotoxicity within 5 days, which, however, significantly increased on day 8. The result demonstrated that more toxic products may be produced during the biodegradation processes of OPs, and more attention should be put not only on the pesticides themselves, but also on the toxic effects of their degradation products. To the best of our knowledge, this is for the first time that the genotoxicity of OP degradation products was evaluated by the bioreporter assay, broadening our understanding on the genotoxic risks of OPs during biodegradation process. Graphical Abstract.


Assuntos
Biodegradação Ambiental , Compostos Organofosforados/metabolismo , Praguicidas/metabolismo , Bacillus cereus/metabolismo , Dano ao DNA , Diclorvós , Dimetoato , Cinética , Solo
3.
Chemosphere ; 218: 252-258, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30471506

RESUMO

Colloids and organics in shale gas fracturing flowback water (SGFFW) during shale gas extraction are of primary concerns. Coagulation combined with oxidation might be a promising process for SGFFW treatment. In this study, a novel electrocoagulation-peroxone (ECP) process was developed for SGFFW treatment by simultaneous coagulation and oxidation process with a Al plate as the anode and a carbon-PTFE gas diffusion electrode as the cathode, realizing the simultaneous processes of coagulation, H2O2 generation and activation by O3 at the cathode. Compared with electrocoagulation (EC) and peroxi-electrocoagulation (PEC), COD removal efficiency mainly followed the declining order of ECP, PEC and EC under the optimal current density of 50 mA cm-2. The appearance of medium MW fraction (1919 Da) during ozonation and PEC but disappearance in ECP indicated that these intermediate products couldn't be degraded by ozonation and PEC but could be further oxidized and mineralized by the hydroxyl radical produced by the cathode in ECP, demonstrating the hydroxyl radical might be responsible for the significant enhancement of COD removal. The pseudo-first order kinetic model can well fit ozonation and EC process but not the PEC and ECP process due to the synthetic effect of coagulation and oxidation. However, the proposed mechanism based model can generally fit ECP satisfactorily. The average current efficiency for PEC was 35.4% and 12% higher than that of ozonation and EC, respectively. This study demonstrated the feasibility of establishing a high efficiency and space-saving electrochemical system with integrated anodic coagulation and cathodic electro-peroxone for SGFFW treatment.


Assuntos
Técnicas Eletroquímicas/métodos , Eletrocoagulação/métodos , Fraturamento Hidráulico/métodos , Gás Natural , Compostos Orgânicos/isolamento & purificação , Purificação da Água/métodos , Carbono , Eletrodos , Radical Hidroxila/química , Cinética , Oxirredução , Ozônio , Ácidos Sulfúricos/química , Poluentes Químicos da Água/análise , Poluentes Químicos da Água/isolamento & purificação
4.
Chemosphere ; 215: 461-469, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30336323

RESUMO

Understanding microbial community structure and diversity in contaminated soils helps optimize the bioremediation strategies and performance. This study investigated the roles of environmental variables and contamination levels of organochlorine pesticides (OCPs) in shaping microbial community structure at an abandoned aged insecticide plant site. In total, 28 bacterial phyla were identified across soils with different physiochemical properties and OCPs levels. Proteobacteria, Bacterioidetes and Firmicutes represented the dominant lineages, and accounted for 60.2%-69.2%, 5.6%-9.7% and 6.7%-9.4% of the total population, respectively. The overall microbial diversities, in terms of phylogenetic diversity and phylotype richness, were correlated with the contents of hexachlorocyclohexanes (HCHs) and dichlorodiphenyltrichloroethanes (DDTs) in soils, as well as other soil properties including total nitrogen, dissolved organic carbon, pH and vegetation. The multivariate regression tree (MRT) analysis revealed that the soil microbial diversity was significantly impacted by vegetation, which explained 31.8% of the total variation, followed by OCPs level (28.3%), total nitrogen (12.4%), dissolved organic carbon (6.3%) and pH (2.4%). Our findings provide new insights and implications into the impacts on soil microbial community by OCPs contamination and other environmental variables, and offer potential strategic bioremediation for the management of OCPs contaminated sites.


Assuntos
Hidrocarbonetos Clorados/análise , Consórcios Microbianos/efeitos dos fármacos , Praguicidas/análise , Filogenia , Poluentes do Solo/análise , Solo/química , Bactérias/genética , Biodegradação Ambiental , China , Hexaclorocicloexano/análise , Hidrocarbonetos Clorados/farmacologia , Consórcios Microbianos/fisiologia , Nitrogênio/análise , Nitrogênio/farmacologia , Praguicidas/farmacologia
5.
J Diabetes Res ; 2018: 3458615, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30116739

RESUMO

Type 2 diabetes (T2D) accounts for about 90% of all diabetes patients and incurs a heavy global public health burden. Up to 50% of T2D patients will eventually develop neuropathy as T2D progresses. Diabetic peripheral neuropathy (DPN) is a common diabetic complication and one of the main causes of increased morbidity and mortality of T2D patients. Obstructive sleep apnea (OSA) affects over 15% of the general population and is associated with a higher prevalence of T2D. Growing evidence also indicates that OSA is highly prevalent in T2D patients probably due to diabetic peripheral neuropathy. However, the interrelations among diabetic peripheral neuropathy, OSA, and T2D hitherto have not been clearly elucidated. Numerous molecular mechanisms have been documented that underlie diabetic peripheral neuropathy and OSA, including oxidative stress, inflammation, endothelin-1, vascular endothelial growth factor (VEGF), accumulation of advanced glycation end products, protein kinase C (PKC) signaling, poly ADP ribose polymerase (PARP), nitrosative stress, plasminogen activator inhibitor-1, and vitamin D deficiency. In this review, we seek to illuminate the relationships among T2D, diabetic peripheral neuropathy, and OSA and how they interact with one another. In addition, we summarize and explain the shared molecular mechanisms involved in diabetic peripheral neuropathy and OSA for further mechanistic investigations and novel therapeutic strategies for attenuating and preventing the development and progression of diabetic peripheral neuropathy and OSA in T2D.


Assuntos
Diabetes Mellitus Tipo 2/complicações , Neuropatias Diabéticas/etiologia , Apneia Obstrutiva do Sono/complicações , Fator A de Crescimento do Endotélio Vascular/metabolismo , Animais , Complicações do Diabetes/complicações , Complicações do Diabetes/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Neuropatias Diabéticas/metabolismo , Progressão da Doença , Endotelina-1/metabolismo , Produtos Finais de Glicação Avançada/metabolismo , Humanos , Camundongos , Neurotransmissores/metabolismo , Estresse Oxidativo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Prevalência , Proteína Quinase C/metabolismo , Ratos , Apneia Obstrutiva do Sono/metabolismo
6.
Exp Ther Med ; 14(2): 1395-1398, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28810602

RESUMO

Hepatitis C virus (HCV) is a major cause of liver-associated morbidity and has an increasing prevalence worldwide. Hepatitis C virus infection may lead to chronic hepatitis, cirrhosis and liver failure. However, it is also associated with a wide range of extra-hepatic complications, such as cryoglobulinemia, an immune complex disease associated with cryoglobulin leading to multiple organ damage and, while the major symptom is vasculitis. The present study reported on a-58-year-old woman who was diagnosed with HCV-associated cryoglobulinemia with skin, kidney and blood system damage and biopsy-proven cryoglobulinemia membrano-proliferative glomerulonephritis. HCV RNA clearance occurred within a few weeks of interferon treatment and the patient was then treated by prednisolone and sustained interferon. While the therapeutic effect was obvious at first, the disease reappeared in combination with refractory infection and multiple organ failure, and the patient finally died. HCV-associated cryoglobulinemia is uncommon in developing countries such as China, while treatment guidelines remain to be established, particularly if complex complications are present.

7.
Int Urol Nephrol ; 48(10): 1691-8, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27272256

RESUMO

OBJECTIVE: To investigate the clinical and histopathological features of non-diabetic renal disease (NDRD) superimposed on diabetic nephropathy (DN) in northeastern Chinese patients with type 2 diabetes mellitus (T2D), and compare the changes with those of pure DN and isolated NDRD. METHODS: Single-center retrospective analysis based on medical records of 273 patients (172 men, mean age: 51.1 ± 12.4 years) with T2D who underwent renal biopsy between February 2000 and October 2015. All patients were diagnosed as cases of pure DN, isolated NDRD or NDRD superimposed on DN. RESULTS: Out of the 273 T2D patients, 68 (24.9 %) had DN, 175 (64.1 %) had NDRD, and 30 (11.0 %) had NDRD superimposed on DN. Idiopathic membranous nephropathy (IMN, 29.7 %) was the most common NDRD followed by IgA nephropathy (IgAN, 22.9 %), and hypertensive renal arteriolar sclerosis was the most common lesion in patients diagnosed as NDRD superimposed on DN. Patients with NDRD had a shorter duration of diabetes and lower frequencies of diabetic retinopathy (DR, 6.9 %) and renal failure (28.0 %), which is consistent with higher estimated glomerular filtration rates (eGFR) and lower systolic blood pressure (SBP). No significant between-group differences were observed with respect to proteinuria and hematuria. CONCLUSION: Renal biopsy is strongly recommended for T2D patients to distinguish DN, NDRD and NDRD superimposed on DN, especially in patients with no signs of DR. This approach may help in early diagnosis and treatment of NDRD and improve renal outcomes in northeastern Chinese T2D patients.


Assuntos
Diabetes Mellitus Tipo 2 , Nefropatias Diabéticas/diagnóstico , Nefropatias/diagnóstico , Rim , Adulto , China/epidemiologia , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/epidemiologia , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/fisiopatologia , Diagnóstico Diferencial , Intervenção Médica Precoce , Feminino , Humanos , Rim/patologia , Rim/fisiopatologia , Nefropatias/fisiopatologia , Testes de Função Renal/métodos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
8.
Cell Biol Int ; 39(5): 548-53, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25597757

RESUMO

The epithelial barrier dysfunction plays a critical role in a number of kidney diseases. The mechanism is unclear. Alix is a protein involving in protein degradation in epithelial cells. This study aims to investigate that interleukin (IL)-13 inhibits Alix to compromise the kidney epithelial barrier function. In this study, the murine collecting duct cell line (M-1) was cultured in Transwell inserts to investigate the significance of Alix in compromising the epithelial barrier functions. T cell (Teff cells) proliferation assay was employed to assess the antigenicity of ovalbumin (OVA) that was transported across the M-1 monolayer barrier. The results showed that M-1 cells express Alix. Exposure to interleukin (IL)-13 markedly decreased the expression of Alix in M-1 cells, which compromised the M-1 monolayer barrier functions by showing the increases in the permeability to OVA. Over-expression of Alix abolished the IL-13-induced M-1 monolayer barrier dysfunction. Knockdown of Alix significantly increased M-1 monolayer permeability. The OVA collected from the Transwell basal chambers induced the OVA-specific T cell proliferation. We conclude that IL-13 compromises M-1 epithelial barrier functions via inhibiting Alix expression.


Assuntos
Proteínas de Ligação ao Cálcio/genética , Permeabilidade da Membrana Celular , Interleucina-13/farmacologia , Túbulos Renais/metabolismo , Urotélio/metabolismo , Animais , Proteínas de Ligação ao Cálcio/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , Permeabilidade da Membrana Celular/genética , Células Cultivadas , Impedância Elétrica , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Túbulos Renais/efeitos dos fármacos , Camundongos , Ovalbumina/metabolismo , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/genética , Urotélio/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA